Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
Funding opportunity to support HIV/AIDS research tackling hearing, balance, taste, smell, voice, speech, & language within NIDCD's mission.
Funder: National Institutes of Health
Due Dates: April 7, 2025 (Open date) | May 7, 2025 (AIDS) | September 7, 2025 (AIDS) | January 7, 2026 (AIDS) | May 7, 2026 (AIDS) | June 5, 2026 (New) | October 5, 2026 (New) | February 5, 2027 (New) | June 5, 2027 (New) | October 5, 2027 (New) | November 5, 2027 (Final closing)
Funding Amounts: Up to $499,999 direct costs/year; max project period 5 years; no cost sharing required.
Summary: Supports research on HIV/AIDS within the mission areas of the NIDCD, focusing on hearing, balance, taste, smell, voice, speech, and language, including low-risk clinical trials.
Description
This funding opportunity stimulates HIV/AIDS research aligned with the scientific mission of the National Institute on Deafness and Other Communication Disorders (NIDCD). Projects should address high-priority HIV/AIDS research as outlined by the NIH Office of AIDS Research (OAR), specifically in the areas of hearing, balance, taste, smell, voice, speech, and language. Both basic and applied research, including low-risk clinical trials, are eligible. The overarching goal is to improve understanding and treatment of communication disorders among people living with HIV (PLWH), ultimately informing prevention and intervention strategies.
Research may include investigations into the impact of HIV and associated co-infections on communication functions, adverse effects of HIV treatments, pathophysiological mechanisms of comorbid disorders, and the development of prevention or treatment strategies. Only low-risk clinical trials are supported (see below for details).
